FONTEYNE PAUL R.

Insider trading activity for FONTEYNE PAUL R. sourced from SEC EDGAR Form 4 filings.

Overview

Date	Insider	Ticker / Company	Type	Shares	Value
May 14, 2026	FONTEYNE PAUL R.	APLS Apellis Pharmaceuticals, Inc.	SELL	5,748	N/A
May 14, 2026	FONTEYNE PAUL R.	APLS Apellis Pharmaceuticals, Inc.	SELL	27,600	N/A
May 14, 2026	FONTEYNE PAUL R.	APLS Apellis Pharmaceuticals, Inc.	SELL	7,441	N/A
May 14, 2026	FONTEYNE PAUL R.	APLS Apellis Pharmaceuticals, Inc.	SELL	8,554	N/A
May 14, 2026	FONTEYNE PAUL R.	APLS Apellis Pharmaceuticals, Inc.	SELL	11,199	N/A
May 14, 2026	FONTEYNE PAUL R.	APLS Apellis Pharmaceuticals, Inc.	SELL	37,500	N/A
May 14, 2026	FONTEYNE PAUL R.	APLS Apellis Pharmaceuticals, Inc.	SELL	14,684	N/A
May 14, 2026	FONTEYNE PAUL R.	APLS Apellis Pharmaceuticals, Inc.	SELL	3,877	N/A
May 14, 2026	FONTEYNE PAUL R.	APLS Apellis Pharmaceuticals, Inc.	SELL	3,544	N/A
May 14, 2026	FONTEYNE PAUL R.	APLS Apellis Pharmaceuticals, Inc.	SELL	7,961	N/A
May 14, 2026	FONTEYNE PAUL R.	APLS Apellis Pharmaceuticals, Inc.	SELL	5,744	N/A
May 14, 2026	FONTEYNE PAUL R.	APLS Apellis Pharmaceuticals, Inc.	SELL	3,062	N/A
May 14, 2026	FONTEYNE PAUL R.	APLS Apellis Pharmaceuticals, Inc.	OTHER	30,666	N/A